The KRAS wildtype tubular carcinoma and one KRAS-mutated tubular carcinoma also lacked alterations in the three other genes (Table 5), a result that was confirmed by additional extended gene analysis. This evidence concerns the gene KRAS and tubular adenocarcinoma.